TE Tirzepatide Editorial

Comparison

Henry Meds Versus Mochi Health

Direct answer

Henry Meds and Mochi Health are compared here on the fields this site can actually verify: normalised recurring tirzepatide cost, the basis of that figure, mandatory fees, and billing cadence. The two are not directly comparable on price, because at least one publishes a figure whose mandatory-fee inclusion is unconfirmed. Pharmacy, clinician, states, and cancellation terms are unverified for both.

Key takeaways

  • A like-for-like price comparison is not possible because fee inclusion is unconfirmed for at least one provider.
  • Henry Meds basis: not normalisable. Mochi Health basis: effective recurring cost: medication plus every mandatory fee, computed from the captured components.
  • Pharmacy identity, licence, states served, dose coverage, and cancellation terms are unverified for both providers and are not compared.
  • Neither provider has any financial, affiliate, referral, or sponsorship relationship with this site.
  • Compounded tirzepatide is not FDA approved regardless of which provider dispenses it.
Current regulatory status — compounded tirzepatide. The FDA determined the tirzepatide shortage resolved on 2 October 2024 and reaffirmed it by declaratory order on 19 December 2024. Enforcement discretion for compounding ended on 18 February 2025 for 503A pharmacies and 19 March 2025 for 503B outsourcing facilities, and a federal court upheld the determination in May 2025. Federal law prohibits compounding a copy of a commercially available approved drug outside a shortage, so routine compounded tirzepatide is no longer permitted. Full timeline and sources.
Key facts
Providers comparedHenry Meds and Mochi Health
Like-for-like on priceNo — fee inclusion unconfirmed
Fields verifiedPricing, fees, billing cadence
Fields pendingPharmacy, licence, clinicians, states, dose coverage, cancellation
Publisher relationshipNone with either provider
Partially verified
Reviewed by Kim Callender, NP, FNP-BC
Published 2026-07-22
Editorially updated 2026-07-22
Fact verified 2026-07-22
Price verified 2026-07-20
Dataset snapshot 2026-07-22
Methodology v1.0

How do these two providers compare side by side?

Henry Meds versus Mochi Health — verified fields only
FieldHenry MedsMochi Health
Normalised monthly costNot normalisable$278
Basis of that figureNot comparableeffective recurring cost: medication plus every mandatory fee, computed from the captured components
Mandatory feesProgram prices generally advertised as including provider services and medicationMembership $39 first month, then $79/month; shipping advertised included
Medication includedYes for listed programsMedication price separate from membership
Billing cadenceMonthly or multi-month prepaidMonthly
Compounding pharmacyPendingPending
Pharmacy licencePendingPending
States servedPendingPending
Dose coveragePendingPending
Cancellation termsPendingPending
Price verified2026-07-202026-07-20
Publisher relationshipNoneNone
Verification Pending. These two providers cannot be ranked against each other on price, because at least one figure is not a recurring all-in cost for the standard injection. The specific reason for each:
  • Henry Meds is excluded — Price stated in free text that cannot be normalised. Captured source text: Oral tirzepatide: 3 months $1,047, or advertised prepaid offer $891 ($297/mo)
  • Mochi Health qualifies: effective recurring cost: medication plus every mandatory fee, computed from the captured components.
Price-classification test applied to each provider in this comparison
ProviderPrice classificationWhy it is or is not rankable
Henry Medsnot normalisablePrice stated in free text that cannot be normalised
Mochi Healthverified all ineffective recurring cost: medication plus every mandatory fee, computed from the captured components

How do Henry Meds and Mochi Health actually differ on the verified fields?

A price comparison between Henry Meds and Mochi Health cannot be made honestly from public information. Henry Meds's figure rests on "no normalisable price" and Mochi Health's on "effective recurring cost: medication plus every mandatory fee, computed from the captured components" — different measurements presented in the same currency, which is precisely how comparison tables mislead.

On fee structure the two records read differently. Henry Meds: Program prices generally advertised as including provider services and medication. Mochi Health: Membership $39 first month, then $79/month; shipping advertised included. Fee structure is the single most common reason an advertised price and an actual charge diverge, so this row deserves more attention than the headline figure.

Billing cadence also differs: Henry Meds publishes "Monthly or multi-month prepaid" while Mochi Health publishes "Monthly". Where one offers a committed tier and the other does not, the comparison is partly between price and flexibility rather than price alone.

Which should you choose?

This site does not name a winner between Henry Meds and Mochi Health. Cost is one field among several, and the ones that would decide it for most people — which pharmacy compounds the drug, whether the price holds at 15 mg, and what happens to prepaid money if you stop — are unverified for both.

The useful action is to put the same questions to each and compare the answers, since a provider's willingness to answer them before payment is itself a signal.

  • Ask Henry Meds and Mochi Health both for the recurring price after any introductory month.
  • Ask both for a complete list of mandatory fees — Henry Meds's record reads "Program prices generally advertised as including provider services and".
  • Ask both to name the compounding pharmacy and its state licence number.
  • Ask both what the total becomes at 10 mg and 15 mg.
  • Ask both for cancellation notice and prepaid-refund terms in writing before paying.
Relationship disclosure. No provider on this site has any financial, ownership, affiliate, referral, or sponsorship relationship with Tirzepatide Editorial. No provider can pay for inclusion, position, or a favourable description.

Full reviews: Henry Meds · Mochi Health · all ranked providers

How much verified evidence exists for each provider?

Recurring price confirmed01Medication inclusion stated11Fee structure stated11Pharmacy identity verified00Cancellation terms verified00Henry MedsMochi Health
Count of verified fields held for each provider (1 = held, 0 = not held). Both providers have unverified pharmacy and cancellation fields, which is why this comparison is limited to pricing and disclosure.
Data for: Verified data fields held: Henry Meds versus Mochi Health
GroupHenry MedsMochi Health
Recurring price confirmed01
Medication inclusion stated11
Fee structure stated11
Pharmacy identity verified00
Cancellation terms verified00
Why Henry Meds and Mochi Health cannot both be placed on one cost axis
ProviderClassificationCaptured source textPublished reason
Henry Medsnot normalisableOral tirzepatide: 3 months $1,047, or advertised prepaid offer $891 ($297/mo)Price stated in free text that cannot be normalised
Mochi Healthverified all inMedication $199/month + membership $79/month after introductory month = about $278/month ongoingeffective recurring cost: medication plus every mandatory fee, computed from the captured components

Frequently asked questions

Is Henry Meds cheaper than Mochi Health?

Not directly comparable — at least one provider's advertised price does not confirm whether mandatory fees are included.

Which has better pharmacy transparency?

Neither has been verified first-party, so no comparison is made.

Does this site earn commission from either?

No. There is no financial, affiliate, referral, or sponsorship relationship with either provider.

What should I ask before choosing?

Recurring price after any introductory month, all mandatory fees, the compounding pharmacy and licence, price at maximum dose, and cancellation terms.

Change history

Substantive changes to this page
DateChange
2026-07-22Page published with current dataset snapshot.

Dates change only for substantive edits, never for cosmetic changes. Corrections: corrections policy.

What else is in this section?